back
Food Allergy Essentials
Common Allergens
Food Allergy 101
Allergy Alerts & Ingredient Notices
Back to School Headquarters
Food Allergy & Anaphylaxis Emergency Care Plan
Recipes
Free Downloadable Resources
Shop Sifter
Information for you
Newly Diagnosed
Children with Food Allergies
Adolescents and Teens
Adults with Allergies
Educators
Healthcare Providers
College Staff
Other Professionals
Join the Community
Join the FARE Community
Find a Support Group

back
Accelerating Innovation
Elevating Care
Pioneering Advances in Diagnosis
Early Introduction and Food Allergy Prevention
Developing Effective Treatments
Elevating Research
FARE Patient Registry
FARE Clinical Network
FARE Data Coordinating Center
FARE Biobank
Clinical Trials
Recently Funded Research
Research Funding Opportunities

Media Room

Releases & Statements

Statement by Sung Poblete, PhD, RN, CEO of FARE in response to the food allergy death of Órla Baxendale following consumption of a cookie manufactured by Cookies United and sold by Stew Leonard’s, which contained undisclosed peanuts

January 25, 2024

FARE Endorses Rep. Maxwell Alejandro Frost’s (D-FL-10) “EPIPEN Act”

January 11, 2024

New Federal Bill Would Cap the Cost of Epinephrine Auto-Injectors at $60 Per Two-Pack

Statement by Sung Poblete, PhD, RN, CEO of FARE, regarding the successful “I CAN” fundraising campaign with OWYN and Brittany Mahomes

January 01, 2024

FARE Announces $1.2M Request For Application to Support Collaborative Projects on Tree Nut Allergy Research

November 27, 2023

Coming Together for Good: A FARE Gala Raises $1,000,000 to Support Food Allergy Research

November 21, 2023

Statement by Sung Poblete, PhD, RN, CEO of FARE, regarding the bullying of a Texas student with a food allergy

November 14, 2023

Statement by Sung Poblete, RN, PhD, CEO of FARE, regarding Olive Garden’s decision to change suppliers and make its breadsticks sesame-free

October 19, 2023

Statement of Jason Linde, Senior Vice President of Advocacy, FARE, on the Muñoz SAFE Act (A.B. 1651) which was signed into law by Governor Newsom

October 10, 2023

FARE Welcomes Genentech as Sponsor to Support the Food Allergy Patient Journey

October 04, 2023

Sponsorship brings the potential for groundbreaking discoveries and solutions for the food allergy community

FARE Food Allergy Summit to Unite Food Allergy Community

October 03, 2023

Experts, Advocates and Innovators Will Transform the Landscape of Food Allergies

Statement by Sung Poblete, RN, PhD, CEO of FARE, regarding the frustration felt by the food allergy community after FDA requests additional information and testing before approving neffy®, a needle-free epinephrine alternative

September 19, 2023

FARE Celebrates New Teacher Training Law in New York

September 18, 2023

After 12 Years, Advocates and Lawmakers Secure Win for 218,000 Schoolchildren

Media Contact:

media@foodallergy.org.

About FARE

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.